CK
Cory Kasimov Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
86.7%
Neutral
13.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $40 |
96%
upside
| 2 | +59% |
0
%
| 16 Dec ‘25 23 days ago |
|
|
|
Outperform
Initiated
| $55 |
235%
upside
| 1 | -59% |
0
%
| 26 Nov ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $35 |
25%
upside
| 1 | +26% |
0
%
| 24 Nov ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $25 |
196%
upside
| 1 | -26% |
0
%
| 20 Nov ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $40 |
45%
upside
| 1 | +7.2% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $80 |
26%
upside
| 1 | +28% |
0
%
| 3 Sep ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $12 |
102%
upside
| 1 | +19% |
0
%
| 3 Sep ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $34 |
81%
upside
| 2 | +9.7% |
0
%
| 12 Aug ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $55 |
33%
upside
| 1 | +39% |
0
%
| 14 May ‘25 7 months ago |
|
|
|
In-Line
Maintained
| $32 |
5%
downside
| 2 | – |
–
| 2 May ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $185 |
36%
upside
| 1 | +31% |
0
%
| 24 Apr ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $65 |
38%
upside
| 1 | -15% |
0
%
| 12 Feb ‘25 11 months ago |
|